HDL CH3811
Ref CH3811
HDL CH3811 is an in vitro diagnostic device (EU IVDD general IVD; FDA Class I; FDA product code LBS, Ldl & Vldl Precipitation, Cholesterol Via Esterase-Oxidase, Hdl) made by Randox Laboratories, Ltd., registered in EUDAMED on 28 Oct 2026 (Basic UDI-DI B-05055273201291), cleared under FDA 510(k) K982341 on 30 Jul 1998 and listed in FDA GUDID since 24 Dec 2018 (UDI-DI 05055273201291), active as of 7 Nov 2026. One FDA recall is linked to it.
Active
Valid until
No date given
FDA recalls
None ongoingTrust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDD EUDAMED | NumberB-05055273201291 05055273201291 | Date28 Oct 2026 | StatusActive |
| United States | GUDID listing GUDID | Number05055273201291 | Date24 Dec 2018 | StatusListed |
| United States | FDA 510(k)SESE GUDID | NumberK982341 | Date30 Jul 1998 | StatusActive |
Official records
- EUDAMED public site B-05055273201291
- AccessGUDID record 05055273201291
- FDA 510(k) database K982341
From the FDA record
- Device description
- An HDL-cholesterol test system is a device intended for the quantitative in vitro determination of HDL-cholesterol concentration in human serum and plasma.
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile
Across registries
- EUDAMED Basic UDI-DI B-05055273201291 registered 28 Oct 2026 Active
- FDA 510(k) K982341 decided 30 Jul 1998 Active
- FDA GUDID UDI-DI 05055273201291 listed 24 Dec 2018 Listed
Certificates
No certifier certificate is listed. Devices of this class are self-declared by the manufacturer.
Recalls
-
- Terminated Z-1653-2016
Siemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may occur on samples drawn from patients receiving N-Acetylcysteine (NAC) or Metamizole. NAC is the accepted antidote for acetaminophen toxicity and is justified in patients at signific
Timeline
- Cleared FDA 510(k) K982341
- Recall initiated FDA recalls Z-1653-2016
- Listed FDA GUDID 05055273201291
- Registered EUDAMED B-05055273201291
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Direct Hdl-Cholesterol (Hdl) EUDAMEDHdl GUDID
- Generic name
- High density lipoprotein (HDL) cholesterol IVD, kit, spectrophotometry
- Model / Ref / Catalog
- CH3811
- Primary DI / UDI-DI
- 05055273201291
- Basic UDI-DI
- B-05055273201291
- 510(k) Number
- FDA product code
- LBS
- EMDN code
- W01010215 High density lipoprotein cholesterol
- GMDN term
- High density lipoprotein (HDL) cholesterol IVD, kit, spectrophotometry
- Device class
- Class IVD General EUDAMEDClass I GUDID
- Regulation number
- 862.1475
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Northern Ireland
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class IVD General | Class I |
Similar devices in this category
Other devices filed under HIGH DENSITY LIPOPROTEIN CHOLESTEROL.
- CREATINE KINASE MB ISOENZYME REAGENT KIT(IMMUNOINHIBITION) 3004586 by DIRUI INDUSTRIAL CO., LTD
- Alinity 07P7530 by Abbott
- Diayzme DZ129A-KY1 by Diazyme Laboratories, Inc.
- HDL Cholesterol Reagent HDL 2 x 200 A15625 by Beckman Coulter, Inc.
- HDL-Cholesterol 981955 by Thermo Fisher Scientific Oy
- CHOLESTEROL HDL SL 2G HDLL-0230 by VITALSCIENTIFIC
- Healthy Heart Check FP0131 by Vital Signs Solutions Ltd.
- Atellica CH HDLC 11537213 by Siemens Healthcare Diagnostics Inc.